MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

24 May 2022 Evaluate
The company witnessed a 13.33% growth in the revenue at Rs. 1065.53 millions for the quarter ended March 2022 as compared to Rs. 940.17 millions during the year-ago period.A good growth in profit of 43.77% reported to Rs. 147.06  millions over Rs. 102.29 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 215.13 millions from 150.69 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1065.53 940.17 13.33 4058.42 3328.44 21.93 4058.42 3328.44 21.93
Other Income 51.60 26.81 92.47 153.83 113.20 35.89 153.83 113.20 35.89
PBIDT 215.13 150.69 42.76 948.56 860.73 10.20 948.56 860.73 10.20
Interest 3.01 3.67 -17.98 4.85 5.00 -3.00 4.85 5.00 -3.00
PBDT 212.12 147.02 44.28 943.71 855.73 10.28 943.71 855.73 10.28
Depreciation 11.93 9.90 20.51 37.95 36.70 3.41 37.95 36.70 3.41
PBT 200.19 137.12 46.00 905.76 819.03 10.59 905.76 819.03 10.59
TAX 53.13 34.83 52.54 233.88 207.14 12.91 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 147.06 102.29 43.77 671.88 611.89 9.80 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 20.19 16.03 25.97 23.37 25.86 -9.62 23.37 25.86 -9.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..